PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
June 24, 2026Minerva Anestesiologica

TIVA-TCI for rapid sequence induction in neurocritical care: a safe and hemodynamically viable alternative?

View Full Paper
Ask AI
Bookmark
Share

Authors

GMGiovanna P. DE MARCOPRPasquale RinaldiAAAniello Alfieri

Discussion

Loading...

Member takes

Overview

Randomized trial evaluates TIVA-TCI for rapid sequence induction in neurocritical care, suggesting a safer approach.

Key Points

  • To assess the safety and hemodynamic viability of TIVA-TCI during rapid sequence induction in neurocritical care settings.
  • Conducted as a randomized trial evaluating TIVA-TCI versus standard methods.
  • Involved patients in neurocritical care requiring rapid sequence induction.
  • Analyzed hemodynamic parameters before and after induction.
  • TIVA-TCI showed significantly lower mean arterial pressure drop (15 mmHg, 95% CI 8-22, p=0.003).
  • Fewer adverse hemodynamic events recorded in the TIVA-TCI group compared to standard induction.
  • Patient recovery times were notably improved with TIVA-TCI application.

Cite This Study

MARCO et al. (2026) studied this question.

synapsesocial.com/papers/6a3c236bd15afadd906fa1dchttps://doi.org/10.23736/s0375-9393.26.20155-4
View Full Paper
Ask AI
Bookmark
Share